Antibiotics - Drug & Class Details Flashcards
Penicillin G
MOA: Cell wall synthesis inhibition stage 3, bactericidal
PK: IM, IV (poor oral); renally excreted
Use limited to hospitalized patients with severe infections:
Gram positive cocci (Strep, entero)
C. perfringens
Penicillin V
MOA: Cell wall synthesis inhibition, stage 3; bactericidal
PK: Oral (acid stable); renally excreted
Gram positive cocci (Strep, Entero)
Anaerobes: C. perfringens
Dicloxacillin
Penicillinase-resistant Penicillin
MOA: Cell wall synthesis inhibition; bactericidal
PK: Oral administration; renal excretion
Spectrum/Uses:
Gram positive cocci (Strep, entero) + MSSA
Amoxicillin +/- Clavulanate
Ampicillin
Extended spectrum Penicillin
MOA: Cell wall synthesis inhibition; bactericidal; Increased hydrophilicity allows penetration through porins of gram negative OM; coupling to B-lactamase inhibitor allows activity against penicillinase-producing organisms
PK: Good Oral, Renally excreted
Spectrum:
Gram positive cocci (strep, entero) + MSSA
Gram negative rods (E. coli)
Anaerobes (C. perfringens, Bacteroides)
Adverse Reactions: Superinfection more likely, diarrhea (ampicillin > amoxicillin due to poorer oral absorption)
Piperacillin +/- Tazobactam
Antipseudomonal Penicillin
MOA: Cell wall synthesis inhibition; bactericidal; coupled to Beta lactamase inhibitor Tazobactam
PK: IV only
Spectrum:
Gram positive cocci (strep, entero) + MSSA
Gram negative rods (E. coli, K. pneumoniae, pseudomonas)
Anaerobes (C. perfringens, Bacteroides)
Cefazolin
1st Generation Cephalosporin
MOA: Cell wall synthesis inhibition, stage 3; bactericidal
PK: Oral absorption, renal elimination
Spectrum:
Gram positive cocci (Strep) + MSSA
Gram negative rods (E. coli, K. pneumoniae)
Adverse Reactions: Cross reactivity (1.5%) with penicillin hypersensitivity
Ceftriaxone
3rd generation Cephalosporin
MOA: Cell wall synthesis inhibition, stage 3; bactericidal
PK: IV, IM absorption with good CNS penetration
Spectrum:
Gram positive cocci (Strep) + MSSA
Gram negative cocci (N. gonorrhea)
Gram negative rods (E. coli, K. pneumoniae)
Vancomycin
MOA: Cell wall synthesis inhibition, stage 2; bactericidal
PK: Poor oral absorption - administered IV (except for GI C. diff); renal elimination
Gram positive cocci (Strep, entero) + MSSA + MRSA
Anaerobes (C. diff)
Adverse reactions: Infusion-related reactions (histamine flushing), nephrotoxicity, ototoxicity; Cp levels must be monitored. Pre-treat with diphenhydramine and acetaminophen.
Erythromycin
Macrolide class
MOA: Protein synthesis inhibition (50S); bacteriostatic
PK: Oral absorption; metabolized in liver and excreted in bile
Spectrum:
Gram positive cocci (Strep, Staph)
Gonorrhea
Atypicals (Mycoplasma, Chlamydia)
ARs: GI upset, DDI due to inhibition of P450 metabolism
Azithromycin
Macrolide class
MOA: Protein synthesis inhibition (50S); bacteriostatic
PK: Oral (empty stomach); biliary excretion
Spectrum:
Gram positive cocci (Strep, Staph)
Gonorrhea
Atypicals (Chlamydia, Mycoplasma)
ARs: GI disturbance (nausea, vomiting, diarrhea)
Clarithromycin
Macrolide class
MOA: Protein synthesis inhibition (50S); bacteriostatic
PK: Absorbed orally, metabolized to active compound that is renally eliminated
Spectrum:
Gram positive cocci (Strep, Staph)
Atypicals (Chlamydia, Mycoplasma)
ARs: GI disturbance, DDI due to inhibition of CYP450
Tetracycline
Tetracycline class
MOA: Protein synthesis inhibition; bacteriostatic
PK: oral administration, renal excretion
Spectrum - Broad (but high resistance)
Gram positive cocci (Strep, Staph + MSSA + MRSA)
Gram negative rods (E. coli, K. pneumoniae,)
Other Gram negatives (V. cholera, H. pylori)
Spirochetes (Borrelia burgdorferi)
Atypical (Mycoplasma, Chlamydia)
Doxycycline
Tetracycline class
MOA: Protein synthesis inhibition; bacteriostatic
PK: Oral administration, biliary excretion; choice for patients with renal disease
Spectrum - Broad (but high resistance)
Gram positive cocci (Strep, Staph + MSSA + MRSA)
Gram negative rods (E. coli, K. pneumoniae)
Atypicals (Mycoplasma, Chlamydia)
Clindamycin
Lincomycin class
MOA: Binds to ribosome preventing translocation of peptidyl tRNA; bacteriostatic
PK: Oral absorption, penetrates most tissues well (especially bone) but not CSF; metabolized by the liver and excreted through the bile
Spectrum:
Gram positive cocci (Strep, Staph + MSSA + MRSA)
Anaerobes (C. perfringens, Bacteroides)
Choice in CA-MRSA
ARs: Selection of C. diff overgrowth leading to pseudomembranous colitis; nausea, diarrhea
Ciprofloxacin
Fluoroquinolone Class, 2nd generation
MOA: Preferential inhibition of DNA gyrase; bactericidal
PK: Oral absorption, primarily renal excretion
Spectrum:
Gram negative rods (E. coli, K. pneumoniae, Pseudomonas)
Atypical (Chlamydia, Mycoplasma)
Levofloxacin
Fluoroquinolone Class, 3rd generation; “respiratory quinolone”
MOA: Inhibition of both DNA gyrase and Topoisomerase IV; bactericidal
PK: Oral absorption, primarily renal excretion
Spectrum
Gram positive cocci (Strep)
Gram negative rods (E. coli, K. pneumoniae, pseudomonas)
Atypical (Chlamydia, Mycoplasma)
Moxifloxacin
Fluoroquinolone Class, 4th generation, “respiratory quinolone)
MOA: Preferential inhibition of Topoisomerase IV; bactericidal
PK: Primarily hepatic excretion (20% renal)
Spectrum
Gram positive cocci (Strep)
Gram negative rods (E. coli, K. pneumoniae)
Atypicals (Chlamydia, Gonorrhea)
Nitrofurantoin
MOA: Reduced in cell to intermediates that damage bacterial DNA; bactericidal
PK: Rapid, complete GI absorption followed by rapid excretion via kidneys (contraindicated in renal impairment); not used for systemic infections because effective Cp cannot be obtained with safe doses
Spectrum:
Gram negative rods (E. coli, K. pneumoniae)
ARs: GI upset, occasional hypersensitivity, neuropathies
Metronidazole
MOA: Reduced intracellularly to active form, a highly reactive radical anion that interferes with DNA function; bactericidal
PK: Oral absorption, distribution includes CSF and bone; hepatic metabolism
Spectrum:
Anaerobes (C. diff, Bacteroides, H. pylori)
Protozoa (trichomoniasis, amebiasis, giardiasis)
ARs: Antabuse-like reaction (via inhibition of aldehyde dehydrogenase), GI upset, candidal superinfections
Penicillins - Adverse Reactions & Toxicity
Type I: Immediate hypersensitivity mediated by IgE & Mast cells (0.05%)
Maculopapular rash most common (1-4%), Diarrhea,
Penicillins - Mechanisms of Resistance
Production of penicillinase enzyme via plasmid transfer
Alterations of penicillin-binding proteins (responsible for MRSA)
Inability to penetrate into bacterial cell
Escape or Persisters - metabolically inactive organisms (“L forms”) that can survive in a hypertonic environment
Penicillins - Pharmacokinetics
Absorption: varies depending on acid stability
Pen G: IV or IM (poor oral)
Pen V, Amoxicillin, and Dicloxacillin: Good oral
Piperacillin: IV only
Distribution: strong acid, largely ionized at physiological pH; penetrates tissues poorly but enters inflamed tissues more easily
Metabolism/Excretion: Excreted as active drug via the kidney; also excreted into breast milk
Cephalosporins - Pharmacokinetics
Absorption: Oral, IV / IM
Distribution: Penetrate well into most tissues and fluids, including placenta; only 3rd gen penetrates into CSF
Metabolism-Excretion: Kidneys, requires renal dosing
Cephalosporins - Adverse Reactions
Hypersensitivity
Cross-hypersensitivity with Penicillins <1% - increased risk with 1st gen
Superinfection - increased risk with 2nd and 3rd gen
Alterations of normal gut flora may decrease synthesis of Vitamin K and intensify the anticoagulant effect of Warfarin
Vancomycin - Pharmacokinetics
Administered IV (poor oral absorption)
Excreted by kidneys; half life is extended in renal failure
Vancomyosin - Adverse Reactions
Ototoxicity, chills, fever, rash, renal toxicity
Routine monitoring of Cp levels required with infusion
B-lactamase Inhibitors
i.e. Clavulanic acid and Tazobactam
Resemble B-lactam molecules; they are potent, irreversible inhibitors of B-lactamase; they are coupled to a penicillins to extend the antibacterial spectrum against resistant organisms that exhibit B-lactamase activity
Clavulanic acid + Amoxicillin
Tazobactam + Piperacillin
Cefazolin
1st Generation Cephalosporin
MOA: Cell wall synthesis inhibition; bactericidal
PK: IV / IM
Spectrum:
Cocci: gram + (Strep, Staph, non MRSA)
Bacilli: gram - (Proteus, diarrhea E. coli, Klebsiella)
Aminoglycosides
MOA: Actively transported into cells (O2-dependent), binds irreversibly to bacterial ribosome, blocking initiation of translation; bacteriocidal
PK: IV/IM (poor oral) absorption; distribution is limited to extracellular fluid (excluded from CNS) but accumulates in renal cortex and inner ear; renal elimination - 1x/daily dosing possible due to concentration-dependent killing and post-antibiotic effect
Spectrum:
Gram negative rods (E. coli, K. pneumoniae, Pseudomonas)
ARs: Very toxic! 8th nerve damage, renal toxicity
Macrolides - Adverse Reactions & Toxicity
GI upset (worse with erythromycin due to direct sitmulation of gut motility)
Hepatotoxicity
Prolonged QT interval
DDIs due to inhibition of CYP450 (erythromycin and clarithromycin only)
Macrolides - Mechanism of Action
Macrolides bind to the 23S ribosomal RNA of the 50S subunit, preventing chain elongation and inhibiting protein synthesis
Tetracyclines - MOA and Resistance
MOA: Binds to ribosomal A site, preventing access of aminoacyl-tRNAs to the ribosomal active site; bacteriostatic
Resistance: Decreased influx, increased efflux, alterations to the ribosome that prevent tetracycline binding
Tetracyclines - Adverse Reactions & Toxicity
Inhibition of bone growth & discoloration of teeth (avoid use < 8 years old)
GI disturbance
DDIs with metal ions (antacids, iron) in stomach
Photosensitivity